Effect of growth hormone on fatty liver in panhypopituitarism
Department of Paediatrics, Okayama
University Medical School, 2-5-1, Shikata-cho Okayama 700, Japan
Correspondence to: Dr Kanzaki.
Accepted 10 March 1997
A 17 year old boy was admitted because of short stature and
hepatomegaly. He was diagnosed with panhypopituitarism and fatty liver.
The fatty liver improved, not with hydrocortisone or levothyroxine treatment, but with growth hormone administration. The fatty liver in
this patient was attributable to a growth hormone deficient state.
© 1997 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Hewitt, K. N., Pratis, K., Jones, M. E. E., Simpson, E. R.
(2004). Estrogen Replacement Reverses the Hepatic Steatosis Phenotype in the Male Aromatase Knockout Mouse. Endocrinology
145: 1842-1848
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



